NamibiaBlindness Therapy Shows Promise
Researchers reveal technique to restore sight in blind people. Optogenetic therapy aims to repair damaged adult retinas.
Global Newsflix 1 min read
Optogenetic therapy MCO-010 may restore vision in advanced macular disease, according to findings presented at EURETINA 2026.
The therapy restored light sensitivity in about half of patients in initial trials.
The technique may offer hope for people with genetic forms of blindness.
Key facts
- Optogenetic therapy MCO-010 aims to restore vision in advanced macular disease.
- The therapy restored light sensitivity in about half of patients in initial trials.
- Findings were presented at EURETINA 2026.
- The technique may offer hope for people with genetic forms of blindness.
Three perspectives
Neutral
The findings are based on preliminary results and require further research. The therapy's long-term effects are not yet known. More studies are needed to confirm the results.
Positive
The technique offers new hope for people with genetic forms of blindness. Restoring light sensitivity can significantly improve quality of life. The therapy has shown promising results in initial trials.
Negative
The therapy is still in its early stages and may not be effective for all patients. The cost and accessibility of the treatment are not yet clear. More research is needed to fully understand the therapy's potential.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.
